Latest Research News
VA Connecticut Healthcare Center and Yale School of Medicine researchers have completed the first well-powered, genome-wide association study of epiretinal membrane, a common retinal disorder that often causes visual distortion or loss of visual acuity. The first author was Joel Gelernter, MD. Co-author was Daniel Levey, PhD.
- June 06, 2024Source: Natural Product Research
Marek Chawarski, PhD, professor of psychiatry and emergency medicine, is senior author of a study in Natural Product Research that explains observed differences in the safety profiles of kratom fresh-leaf preparations consumed in Southeast Asia with highly processed and oxidated products labelled “kratom” primarily consumed in the United States and other countries.
- May 24, 2024
Yale researchers who conducted the largest human brain analysis from a single-cell perspective hope their findings lead to better prediction of medicine that will target certain cells.
- April 14, 2024Source: News 12 Connecticut
Marina Picciotto, PhD, Charles B. G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, spoke to News 12 Connecticut about her research into nicotine addiction. Picciotto is affiliated with the Yale Tobacco Center of Regulatory Science (TCORS).
- March 06, 2024
Yale researchers Dibyadeep Datta, PhD, assistant professor of psychiatry, and Amy Arnsten, PhD, Albert E. Kent Professor of Neuroscience and professor of psychology, led a study that probed a blood biomarker for early-stage Alzheimer’s disease. The findings were published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
- February 06, 2024
A new study by VA Connecticut Healthcare System and Yale School of Medicine researchers assesses how the most up-to-date genetic and psychosocial predictors of opioid use disorder compare and combine when predicting the risk of becoming dependent on opioids.
- January 16, 2024
Patients who use cannabis while being medically treated for opioid use disorder are not at greater risk of returning to non-medical opioid use, a new meta-analysis by Yale researchers reveals. Joao P. De Aquino, MD, assistant professor of psychiatry, and Julio Nunes, MD, a second-year psychiatry resident, are co-authors.
- January 16, 2024
The Department of Veterans Affairs’ Veterans Benefits Administration denied a higher percentage of service-connection disability benefits claims by people who suffered from posttraumatic stress disorder related to military sexual trauma than for people who submitted PTSD combat-related claims, according to a new study by Yale researchers, including lead author Aliya Webermann, PhD, and senior author Anne Black, PhD.
- January 02, 2024Source: Cambridge University Press
Carlos Grilo, PhD, professor of psychiatry and of psychology; Janet Lydecker, PhD, assistant professor of psychiatry; and Ralitza Gueorguieva, PhD, senior research scientist in biostatistics, are co-authors of a paper in Cambridge University Press that tests the efficacy of naltrexone/bupropion maintenance treatment among responders to acute treatments for binge eating disorder.
- December 20, 2023Source: Molecular Psychiatry
A review in Molecular Psychiatry concluded ketamine-assisted electroconvulsive therapy is tolerable and may be efficacious in improving depressive symptoms, but a relative adverse impact on cognition may be an important clinical consideration. Greg Rhee, PhD, assistant professor adjunct of psychiatry, was the lead author.